Nanomedicine News

RSS

Two-Photon Laser Triggers Nanoparticles to Release Chemotherapy Drugs Directly in Tumor Cells

Researchers from UCLA's Jonsson Comprehensive Cancer Center have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength.

From University of California, Los Angeles 28 Feb 2014

Novavax and HHS-BARDA Extend Contract for Development of Recombinant Influenza Vaccines

Novavax, Inc. announced today the execution of a contract modification to extend the base period of performance of its current contract with the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) for the advanced development of Novavax' recombinant seasonal and pandemic influenza vaccines.

From Novavax Inc. 28 Feb 2014

Advances in Using Nanoparticles and Magnetism to Treat Cancer

Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer.

26 Feb 2014

New Nanoscale Drug-Delivery System to Tackle Aggressive Ovarian Cancer

Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, and one in 100 will ultimately die of the condition.

25 Feb 2014

Video Captures Infection of Cells by Virus-Like Particles

Tiny and swift, viruses are hard to capture on video. Now researchers at Princeton University have achieved an unprecedented look at a virus-like particle as it tries to break into and infect a cell. The technique they developed could help scientists learn more about how to deliver drugs via nanoparticles — which are about the same size as viruses — as well as how to prevent viral infection from occurring.

25 Feb 2014

Nanoparticle System Precisely Delivers Anti-Inflammatory Drugs to out of Control Immune Cells

Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts. Their findings were published online Feb. 23 in Nature Nanotechnology.

24 Feb 2014

RBCC-n3D JV Well-Positioned to Capitalize on Rise of 3D Printing in Medicine

As Rainbow Coral Corp. works to market and develop an innovative new 3D bioprinting system, new 3D printing innovations are generating massive new demand for the technology from patients and doctors alike in the medical industry.

24 Feb 2014

NanoViricides’ Modern R&D Lab and cGMP Clinical Production Facility in Shelton Nears Completion

NanoViricides, Inc. (the "Company") reported today that construction of the modern R&D Lab and cGMP Clinical Production facility in Shelton, CT, is nearing completion with some weather-related delays. The Company reports that the R&D lab section of the facility is ahead of schedule. Once construction of the cGMP Clean Room Production Suite is completed, the project will enter the facility testing and validation phase.

From NanoViricides, Inc 21 Feb 2014

Specially Designed Nanovalves in Nanoparticles Control Release of Anticancer Drugs

Researchers from the cancer nanotechnology and signal transduction and therapeutics programs of UCLA’s Jonsson Comprehensive Cancer Center (JCCC) have developed an innovative technique that can carry chemotherapy safely and release it inside cancer cells when triggered by two-photon laser in the infrared red wave length.

From University of California, Los Angeles 21 Feb 2014

Global Industry Analysis Report on Nanomedicine Market

Research and Markets has announced the addition of the "Nanomedicine Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019" report to their offering.

From Research and Markets 20 Feb 2014